Vivakor, Inc.

As of November 21, 2022, Vivakor, Inc. has been downgraded to "risky" due to overvaluation concerns, reflected in its low Price to Book Value of 0.34 and alarming EV to EBITDA ratio of -53.69, while its year-to-date return of -50.42% significantly lags behind the S&P 500's 12.22%.

As of November 21, 2022, Vivakor, Inc. is considered a risky investment due to its significant losses, negative returns, and underperformance compared to peers, with key ratios indicating it is overvalued.

As of June 2, 2025, Vivakor, Inc. shows a mildly bearish trend due to bearish daily moving averages and Bollinger Bands, despite some mildly bullish signals from the weekly MACD and KST, indicating potential for further downside.

Vivakor, Inc. is a micro-cap company in the specialty chemicals industry, reporting net sales of $37 million and a net loss of $8 million as of March 2025. It has a market cap of $36.93 million, with key metrics indicating a P/E ratio of NA and a debt-to-equity ratio of 0.62.

As of Jun 18, Vivakor, Inc. has a market capitalization of 36.93 million and reported net sales of 111.13 million with a net loss of 31.97 million over the last four quarters. The balance sheet shows shareholder's funds of 119.24 million and total assets of 241.04 million.